BROGI, SIMONE Statistiche
BROGI, SIMONE
DIPARTIMENTO DI FARMACIA
Combining Subtractive Genomics with Computer-Aided Drug Discovery Techniques to Effectively Target S. sputigena in Periodontitis
2025-01-01 Praveen, M.; Sree, C. G.; Brogi, S.; Calderone, V.; Dalei, K. P. K. P.
DNA gyrase-inhibitory antimicrobial anthraquinone from the endophytic Sordariomycetes fungus Diaporthe perseae
2025-01-01 Manzano, Joe Anthony H.; Abanto, John Cyril D.; Dayo, Beaver Andrei F.; Llames, Lloyd Christian J.; Gonzaga, Mary Grace E.; Brogi, Simone; Macabeo, Allan Patrick G.
Editorial: Pharmacokinetics modeling in the Artificial Intelligence Era
2025-01-01 Brogi, S.; Schyman, P.; Siramshetty, V. B.
Exploiting COX-2 engagement for amplifying anticancer potential of Quinazoline-triazole conjugates with superior EGFR/VEGFR-2 inhibition
2025-01-01 Serag, M. I.; Hamdi, A.; Nasr, E. E.; Elnagar, M. R.; Tawfik, M. M.; El-Azab, A. S.; Brogi, S.; Al-Suwaidan, I. A.; Hefnawy, M.; Abdel-Aziz, A. A. -M.
Exploring Type II Diabetes Inhibitors from Genus Daphne Plant-species: An Integrated Computational Study
2025-01-01 Nazir, Hafiza Ayesha; Shafiq, Nusrat; Brogi, Simone; Nazli, Zill-I-Huma; Khan, Jallat; Rashid, Maryam; Parveen, Shagufta
Hydroxyl carboxylic acid receptor-2 (HCAR2) as a potential target in neurometabolic diseases
2025-01-01 Testai, Lara; Guida, Francesca; Salerno, Silvia; Brogi, Simone; Morace, Andrea Maria; Carbonetti, Leonardo; Ricciardi, Federica; Perrone, Michela; Palazzo, Enza; Calderone, Vincenzo; Maione, Sabatino; Luongo, Livio
In Silico Exploration of Potential Inhibitors Targeting SARS-CoV-2 Non-Structural Protein 15 (Nsp15): A Comprehensive Overview of Current Research
2025-01-01 Yazdani, B.; Sirous, H.; Farzam, F.; Ansarizadeh, S.; Karimi Taheri, M.; Pourmohammad-Hosseini, G.; Noei, M.; Daneshipour, K.; Shakeri, D.; Houshangi, M.; Calderone, V.; Brogi, S.
Microbial Fermentation in Food and Beverage Industries: Innovations, Challenges, and Opportunities
2025-01-01 Praveen, M.; Brogi, S.
Natural Compounds from Alhagi maurorum as Potential HCC and HepG2 Inhibitors: An Integrated Study using Pharmacophore Development, Molecular Docking, MD Simulation, and DFT Approaches
2025-01-01 Moveed, Aniqa; Parveen, Shagufta; Shafiq, Nusrat; Ali, Awais; Rashid, Maryam; Bourhia, Mohammed; Msanda, Fouad; Salamatullah, Ahmad Mohammad; Brogi, Simone
Novel Antiviral Agents: Synthesis, Molecular Modelling Studies and Biological Investigation, 2nd Edition
2025-01-01 Brogi, S.
Pharmacological Investigation of a Novel Resveratrol-like SIRT1 Activator Endowed with a Cardioprotective Profile
2025-01-01 Carbonetti, Leonardo; Brogi, Simone; D'Orsi, Rosarita; Lessi, Marco; Calderone, Vincenzo; Testai, Lara; Bellina, Fabio
Synthesis and biological investigation of peptidomimetic SARS-CoV-2 main protease inhibitors bearing quinoline-based heterocycles at P3
2025-01-01 Rossi, S.; Deidda, G.; Fiaschi, L.; Ibba, R.; Pieroni, M.; Dichiara, M.; Carullo, G.; Butini, S.; Ramunno, A.; Brogi, S.; Lolicato, M.; Arrigoni, C.; Cabella, N.; Bavagnoli, L.; Maga, G.; Varasi, I.; Biba, C.; Vicenti, I.; Gemma, S.; Crespan, E.; Zazzi, M.; Campiani, G.
Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors
2025-01-01 Carullo, G.; Piano, I.; Salamone, G.; Corsi, F.; Orsini, N.; Dichiara, M.; Cursaro, I.; Fontana, A.; Galante, A.; Contri, C.; Guadagno, L.; Caroli, J.; Mattevi, A.; Vincenzi, F.; Varani, K.; Brogi, S.; Gemma, S.; Butini, S.; Gargini, C.; Strettoi, E.; Campiani, G.
A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients
2024-01-01 Rossi, S.; Tatangelo, V.; Dichiara, M.; Butini, S.; Gemma, S.; Brogi, S.; Pasquini, S.; Cappello, M.; Vincenzi, F.; Varani, K.; Lopresti, L.; Malchiodi, M.; Carrara, C.; Gozzetti, A.; Bocchia, M.; Marotta, G.; Patrussi, L.; Carullo, G.; Baldari, C. T.; Campiani, G.
A virtual insight into mushroom secondary metabolites: 3D-QSAR, docking, pharmacophore-based analysis and molecular modeling to analyze their anti-breast cancer potential
2024-01-01 Shafiq, N.; Shakoor, B.; Yaqoob, N.; Parveen, S.; Brogi, S.; Mohammad Salamatullah, A.; Rashid, M.; Bourhia, M.
Antitumor Activity and Multi-Target Mechanism of Phenolic Schiff Bases Bearing Methanesulfonamide Fragments: Cell Cycle Analysis and a Molecular Modeling Study
2024-01-01 Abdel-Aziz, A. A. M.; El-Azab, A. S.; Brogi, S.; Ayyad, R. R.; Al-Suwaidan, I. A.; Hefnawy, M.
Carotenoid Interactions with PCSK9: Exploring Novel Cholesterol-Lowering Strategies
2024-01-01 Medoro, A.; Scapagnini, G.; Brogi, S.; Jafar, T. H.; Trung, T. T.; Saso, L.; Davinelli, S.
Development of Novel 1,3,4-Trisubstituted Pyrazole Derivatives Bearing Sulfonamide Moiety as Anticancer Agents Targeting JNK Kinases
2024-01-01 Shams, A. A.; Abdel-Maksoud, M. S.; Mohamed, A. A. B.; Brogi, S.; Moustafa, M. A.; El-kerdawy, M. M.
Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. SARs, Structural Analysis, and Biological Characterization
2024-01-01 Butini, S.; Grether, U.; Jung, K. -M.; Ligresti, A.; Allara, M.; Postmus, A. G. J.; Maramai, S.; Brogi, S.; Papa, A.; Carullo, G.; Sykes, D.; Veprintsev, D.; Federico, S.; Grillo, A.; Di Guglielmo, B.; Ramunno, A.; Stevens, A. F.; Heer, D.; Lamponi, S.; Gemma, S.; Benz, J.; Di Marzo, V.; van der Stelt, M.; Piomelli, D.; Campiani, G.
Editorial: Design and development of new therapeutics against infectious diseases using computational and experimental approaches
2024-01-01 Brogi, S.; Sen Gupta, P. S.; Mishra, Y. K.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Combining Subtractive Genomics with Computer-Aided Drug Discovery Techniques to Effectively Target S. sputigena in Periodontitis | 1-gen-2025 | Praveen, M.; Sree, C. G.; Brogi, S.; Calderone, V.; Dalei, K. P. K. P. | |
| DNA gyrase-inhibitory antimicrobial anthraquinone from the endophytic Sordariomycetes fungus Diaporthe perseae | 1-gen-2025 | Manzano, Joe Anthony H.; Abanto, John Cyril D.; Dayo, Beaver Andrei F.; Llames, Lloyd Christian J.; Gonzaga, Mary Grace E.; Brogi, Simone; Macabeo, Allan Patrick G. | |
| Editorial: Pharmacokinetics modeling in the Artificial Intelligence Era | 1-gen-2025 | Brogi, S.; Schyman, P.; Siramshetty, V. B. | |
| Exploiting COX-2 engagement for amplifying anticancer potential of Quinazoline-triazole conjugates with superior EGFR/VEGFR-2 inhibition | 1-gen-2025 | Serag, M. I.; Hamdi, A.; Nasr, E. E.; Elnagar, M. R.; Tawfik, M. M.; El-Azab, A. S.; Brogi, S.; Al-Suwaidan, I. A.; Hefnawy, M.; Abdel-Aziz, A. A. -M. | |
| Exploring Type II Diabetes Inhibitors from Genus Daphne Plant-species: An Integrated Computational Study | 1-gen-2025 | Nazir, Hafiza Ayesha; Shafiq, Nusrat; Brogi, Simone; Nazli, Zill-I-Huma; Khan, Jallat; Rashid, Maryam; Parveen, Shagufta | |
| Hydroxyl carboxylic acid receptor-2 (HCAR2) as a potential target in neurometabolic diseases | 1-gen-2025 | Testai, Lara; Guida, Francesca; Salerno, Silvia; Brogi, Simone; Morace, Andrea Maria; Carbonetti, Leonardo; Ricciardi, Federica; Perrone, Michela; Palazzo, Enza; Calderone, Vincenzo; Maione, Sabatino; Luongo, Livio | |
| In Silico Exploration of Potential Inhibitors Targeting SARS-CoV-2 Non-Structural Protein 15 (Nsp15): A Comprehensive Overview of Current Research | 1-gen-2025 | Yazdani, B.; Sirous, H.; Farzam, F.; Ansarizadeh, S.; Karimi Taheri, M.; Pourmohammad-Hosseini, G.; Noei, M.; Daneshipour, K.; Shakeri, D.; Houshangi, M.; Calderone, V.; Brogi, S. | |
| Microbial Fermentation in Food and Beverage Industries: Innovations, Challenges, and Opportunities | 1-gen-2025 | Praveen, M.; Brogi, S. | |
| Natural Compounds from Alhagi maurorum as Potential HCC and HepG2 Inhibitors: An Integrated Study using Pharmacophore Development, Molecular Docking, MD Simulation, and DFT Approaches | 1-gen-2025 | Moveed, Aniqa; Parveen, Shagufta; Shafiq, Nusrat; Ali, Awais; Rashid, Maryam; Bourhia, Mohammed; Msanda, Fouad; Salamatullah, Ahmad Mohammad; Brogi, Simone | |
| Novel Antiviral Agents: Synthesis, Molecular Modelling Studies and Biological Investigation, 2nd Edition | 1-gen-2025 | Brogi, S. | |
| Pharmacological Investigation of a Novel Resveratrol-like SIRT1 Activator Endowed with a Cardioprotective Profile | 1-gen-2025 | Carbonetti, Leonardo; Brogi, Simone; D'Orsi, Rosarita; Lessi, Marco; Calderone, Vincenzo; Testai, Lara; Bellina, Fabio | |
| Synthesis and biological investigation of peptidomimetic SARS-CoV-2 main protease inhibitors bearing quinoline-based heterocycles at P3 | 1-gen-2025 | Rossi, S.; Deidda, G.; Fiaschi, L.; Ibba, R.; Pieroni, M.; Dichiara, M.; Carullo, G.; Butini, S.; Ramunno, A.; Brogi, S.; Lolicato, M.; Arrigoni, C.; Cabella, N.; Bavagnoli, L.; Maga, G.; Varasi, I.; Biba, C.; Vicenti, I.; Gemma, S.; Crespan, E.; Zazzi, M.; Campiani, G. | |
| Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors | 1-gen-2025 | Carullo, G.; Piano, I.; Salamone, G.; Corsi, F.; Orsini, N.; Dichiara, M.; Cursaro, I.; Fontana, A.; Galante, A.; Contri, C.; Guadagno, L.; Caroli, J.; Mattevi, A.; Vincenzi, F.; Varani, K.; Brogi, S.; Gemma, S.; Butini, S.; Gargini, C.; Strettoi, E.; Campiani, G. | |
| A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients | 1-gen-2024 | Rossi, S.; Tatangelo, V.; Dichiara, M.; Butini, S.; Gemma, S.; Brogi, S.; Pasquini, S.; Cappello, M.; Vincenzi, F.; Varani, K.; Lopresti, L.; Malchiodi, M.; Carrara, C.; Gozzetti, A.; Bocchia, M.; Marotta, G.; Patrussi, L.; Carullo, G.; Baldari, C. T.; Campiani, G. | |
| A virtual insight into mushroom secondary metabolites: 3D-QSAR, docking, pharmacophore-based analysis and molecular modeling to analyze their anti-breast cancer potential | 1-gen-2024 | Shafiq, N.; Shakoor, B.; Yaqoob, N.; Parveen, S.; Brogi, S.; Mohammad Salamatullah, A.; Rashid, M.; Bourhia, M. | |
| Antitumor Activity and Multi-Target Mechanism of Phenolic Schiff Bases Bearing Methanesulfonamide Fragments: Cell Cycle Analysis and a Molecular Modeling Study | 1-gen-2024 | Abdel-Aziz, A. A. M.; El-Azab, A. S.; Brogi, S.; Ayyad, R. R.; Al-Suwaidan, I. A.; Hefnawy, M. | |
| Carotenoid Interactions with PCSK9: Exploring Novel Cholesterol-Lowering Strategies | 1-gen-2024 | Medoro, A.; Scapagnini, G.; Brogi, S.; Jafar, T. H.; Trung, T. T.; Saso, L.; Davinelli, S. | |
| Development of Novel 1,3,4-Trisubstituted Pyrazole Derivatives Bearing Sulfonamide Moiety as Anticancer Agents Targeting JNK Kinases | 1-gen-2024 | Shams, A. A.; Abdel-Maksoud, M. S.; Mohamed, A. A. B.; Brogi, S.; Moustafa, M. A.; El-kerdawy, M. M. | |
| Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. SARs, Structural Analysis, and Biological Characterization | 1-gen-2024 | Butini, S.; Grether, U.; Jung, K. -M.; Ligresti, A.; Allara, M.; Postmus, A. G. J.; Maramai, S.; Brogi, S.; Papa, A.; Carullo, G.; Sykes, D.; Veprintsev, D.; Federico, S.; Grillo, A.; Di Guglielmo, B.; Ramunno, A.; Stevens, A. F.; Heer, D.; Lamponi, S.; Gemma, S.; Benz, J.; Di Marzo, V.; van der Stelt, M.; Piomelli, D.; Campiani, G. | |
| Editorial: Design and development of new therapeutics against infectious diseases using computational and experimental approaches | 1-gen-2024 | Brogi, S.; Sen Gupta, P. S.; Mishra, Y. K. |